Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP424287.RApQzV0T9iBrBL0HxkjR3EwMnlk84mkTgXvcffDPKapms130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP424287.RApQzV0T9iBrBL0HxkjR3EwMnlk84mkTgXvcffDPKapms130_assertion type Assertion NP424287.RApQzV0T9iBrBL0HxkjR3EwMnlk84mkTgXvcffDPKapms130_head.
- NP424287.RApQzV0T9iBrBL0HxkjR3EwMnlk84mkTgXvcffDPKapms130_assertion description "[2) There was no statistical difference in the prevalence of scoliosis between the GH treatment group (32.8%) and the GH nontreatment group (group with no GH treatments) (46.5%) (p=.16, chi-square test).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP424287.RApQzV0T9iBrBL0HxkjR3EwMnlk84mkTgXvcffDPKapms130_provenance.
- NP424287.RApQzV0T9iBrBL0HxkjR3EwMnlk84mkTgXvcffDPKapms130_assertion evidence source_evidence_literature NP424287.RApQzV0T9iBrBL0HxkjR3EwMnlk84mkTgXvcffDPKapms130_provenance.
- NP424287.RApQzV0T9iBrBL0HxkjR3EwMnlk84mkTgXvcffDPKapms130_assertion SIO_000772 19665940 NP424287.RApQzV0T9iBrBL0HxkjR3EwMnlk84mkTgXvcffDPKapms130_provenance.
- NP424287.RApQzV0T9iBrBL0HxkjR3EwMnlk84mkTgXvcffDPKapms130_assertion wasDerivedFrom befree-20150227 NP424287.RApQzV0T9iBrBL0HxkjR3EwMnlk84mkTgXvcffDPKapms130_provenance.
- NP424287.RApQzV0T9iBrBL0HxkjR3EwMnlk84mkTgXvcffDPKapms130_assertion wasGeneratedBy ECO_0000203 NP424287.RApQzV0T9iBrBL0HxkjR3EwMnlk84mkTgXvcffDPKapms130_provenance.